Observational / Non-Interventional Studies

 

The results and citations are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free by clicking the link below.

 

Mental Health/Neuroscience

Observational / Non-Interventional Studies on Lilly products may also be sponsored and reported by parties other than Lilly in other clinical trial registries.

Observational / Non-Interventional Study Results

The following studies have been conducted for products in the mental health/neuroscience therapeutic area.

Drug Disease Trial ID Trial
Phase		 Results
Atomoxetine Attention Deficit Hyperactivity Disorder 12067 4 Treatment Adherence and Compliance in Children and Adolescents on ADHD Medication and Emotional Expression in Clinical Practice
Atomoxetine Attention Deficit Hyperactivity Disorder 12414 4 Safety Study of Atomoxetine and Cerebrovascular Outcomes
Duloxetine Major Depressive Disorder 11539 4 Multi-Country Observational Study to Collect the Frequency of Sexual Dysfunction With Antidepressant Treatment, Either With SSRIs or Duals at 8 Weeks and 6 Months
Duloxetine Depression 12016 4 A Propensity-Matched Retrospective Cohort Study of Antidepressant Drug Exposure and Risk of Suicide Attempt in Adults from a Large U.S. Managed Care Population
Fluoxetine   13947   Meta-Analysis of Observational Studies on First-Trimester Fluoxetine Exposure and Major Fetal Malformations
Olanzapine Schizophrenia
Bipolar Disorder		 11610 4 An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients
Permax Parkinson's Disease 10245 4 Observational Study to Determine the Incidence of New-Onset Cardiac Valvulopathy in Patients Treated With Pergolide as Second-Line Therapy for Parkinson's Disease